Clinical Trial Update: Anlotinib Capsules in the Treatment for IPF/PF-ILDs [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on Anlotinib capsules for idiopathic pulmonary fibrosis and progressive fibrosing interstitial lung disease. The Phase 2/3 study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis
• Progressive Fibrosing Interstitial Lung Disease

Drugs mentioned

• Anlotinib (anlotinib)

Snippet

Sponsor: First Affiliated Hospital of Wenzhou Medical University | Conditions: Interstitial Lung Diseases | Phase 2, Phase 3 | Status: RECRUITING